| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | -100.0% | — |
| R&D Expense | $28.5M | +28.1% | -26.6% |
| SG&A Expense | $5.3M | -17.8% | -33.2% |
| Operating Income | -$33.8M | -23.5% | +27.7% |
| Pre-tax Income | -$35.3M | -23.0% | +19.6% |
| Income Tax | $0 | -100.0% | — |
| Net Income | -$35.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $153.1M | -17.9% | -22.0% |
| Current Assets | $161.4M | -16.8% | -22.2% |
| Total Assets | $177.5M | -16.3% | -20.3% |
| Current Liabilities | $36.0M | -7.6% | -18.4% |
| Long-term Debt | $99.9M | +0.6% | — |
| Total Liabilities | $140.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$99.7M | — | — |
| Capital Expenditures | $31K | — | — |
| Investing Cash Flow | -$28K | — | — |
| Financing Cash Flow | $100.2M | — | — |
| Free Cash Flow | -$99.7M | — | — |
| +19.6% |
| EPS (Basic) | -$2.28 | -23.2% | +19.7% |
| EPS (Diluted) | -$2.28 | -23.2% | +19.7% |
| -2.0% |
| +218.9% |
| Stockholders' Equity | $36.8M | -46.3% | -79.4% |